{
    "nctId": "NCT03990610",
    "briefTitle": "An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction",
    "officialTitle": "Assessment of Outcomes Following Prophylactic Lymph Node Transfer in Patients Undergoing Autologous Breast Reconstruction",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "Incidence rate of lymphedema development",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who have undergone treatment (mastectomy, axillary lymph node dissection \\[ALND\\], radiation and chemotherapy) for breast cancer and are seeking breast reconstruction\n\nExclusion Criteria:\n\n* Patients that are known to be pregnant at the time of surgery\n* Patients with a known hypersensitivity to indocyanine green (ICG) and/or isosulfan blue (Lymphazurin)",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}